1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Key Pharma News 19 JANUARY 2015

Key Pharma News 19 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 34 pages

Industry Trend Analysis - Payer Pressure Forces Gilead/AbbVie Drug Pricing Battle To Remain Heated
Industry Trend Analysis - Investment In Alzheimer's R&D To Continue With Focus On Mild Disease
Industry Brief - Vanda To Regain US/Canadian Rights To Fanapt
Industry Brief - Amgen/Kite Collaborate To Develop CAR T-Cell Immunotherapies
Industry Brief - Vectura/Janssen Sign Deal To Develop Anti-Inflammatory Therapy
Industry Brief - KHK/Syndax Sign Deal To Develop Entinostat In Japan/Korea
Industry Brief - Otsuka Reports Termination Of Contracts With OTS/Fuso Pharmaceutical Industries
Industry Brief - Seattle Genetics/BMS Enter Clinical Trial Collaboration For Adcetris/Opdivo
Industry Brief - Mersana/Takeda Expand Fleximer-ADC Collaboration
Industry Trend Analysis - Incyte/Agenus Collaboration Raises Profile In Immuno-Oncology Market
Industry Brief - MedImmune/Omnis Sign Licensing Deal For Oncolytic Viruses In Immuno-Oncology
Industry Brief - Merck/Lilly Enter Collaboration For Keytruda Combination Regimens
Industry Trend Analysis - Expanded Portfolio Will Help Biogen Idec Sustain Growth
Industry Brief - Cardio3 Enters Immuno-Oncology Space With OnCyte Acquisition
Industry Brief - Shire To Acquire NPS Pharma
Industry Brief - Otsuka Completes Avanir Acquisition
Industry Brief - Tekmira/OnCore Merge To Create Global HBV Company
Industry Trend Analysis - Roche's Majority Stake In Foundation Medicine Will Bolster NGS Oncology Efforts
Industry Trend Analysis - High NME FDA Approvals In 2014 Indicates New Era For Anti-Infectives
Industry Brief - Daiichi Sankyo Pays USD39mn To Settle Kickback Allegations
Industry Trend Analysis - Incentives Will Continue To Generate Interest In Orphan Diseases
Industry Trend Analysis - Resubmitted Cariprazine Can Expect Slow Sales Growth
Industry Trend Analysis - US HCV Drug Pricing Battle To Extend To Europe
Industry Brief - FDA Approves Rytary For PD
Industry Trend Analysis - South African ARV Tender Will Increase Rewards And Pressure On Generic Firms
Industry Brief - Mundipharma Receives Positive EC Decision On Targin For RLS
Industry Brief - Praluent MAA Accepted For Review By EMA
Industry Brief - Health Canada Approves Novartis' Fluad Pediatric Flu Vaccine
Industry Brief - Gilead/CVS Team Up For HCV Drugs
Industry Trend Analysis - US Approval Of Sandoz' Filgrastim Advances With Small Steps, Not Giant Leaps
Industry Brief - FDA Approves AbbVie's Duopa For Motor Fluctuations In Advanced PD Patients
Industry Brief - Chipscreen Receives Chinese Approval For Epidaza In PTCL
Industry Brief - FDA Approves Savaysa For NVAF/VTE
Industry Trend Analysis - Colchicine Marketing Battle To Re-Emerge In US
Industry Brief - Health Canada Approves Actemra For Early RA
Industry Trend Analysis - UK Political Parties Provide Limited Options For A Sustainable Cancer Drugs Fund
Industry Trend Analysis - Gilead Likely To Weather The Indian Sofosbuvir Patent Rejection Storm
Industry Trend Analysis - Keytruda/Opdivo Competition To Intensify
Industry Brief - Perampanel Phase III Trial Conducted In Asia Meets Primary Endpoint
Industry Brief - Positive Results Reported From First Phase III Trials Of Alirocumab
Industry Brief - Phase II/III And III Trials Of Rasagiline For PD Start In Japan
Industry Brief - First Of Three Sativex Phase III Cancer Pain Trials Misses Primary Endpoint
Industry Brief - Cempra Announces Positive Top-Line Phase III Results For Oral Solithromycin In CABP
Industry Trend Analysis - SABCS Highlights Focus On HER2- And PD-1-Targeting Drugs For BC
Industry Brief - Nivolumab Receives PMI Status For Advanced Melanoma

Table Of Contents

Key Pharma News 19 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Flat-Rate Access to R&D Database & Reports from La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

  • $ 8470
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing - R&D Drug Pipeline Database: 1-Year Subscription - Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-yea ...

Bioprinting: Technologies and Global Markets

Bioprinting: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Understand market dynamics of bioprinting technologies, applications, and end-user industries. - Assess specific bioprinting-related industries, including 3-D cell culture; bioinks; ...

Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

  • $ 6328
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global stem cell assay market is expected to reach USD 1,363.3 million by 2021 from USD 536.6 million in 2016, at a CAGR of 20.5% from 2016 to 2021. Factors such as high prevalence of chronic diseases, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.